Ovarian cancer risk lowered by contraceptive pill

By Admin
The worlds biggest cancer charity, Cancer Research UK, has found women who take oral contraceptive pills for a period of 10 years or more almost half t...

The world’s biggest cancer charity, Cancer Research UK, has found women who take oral contraceptive pills for a period of 10 years or more almost half their chances of developing ovarian cancer.

When compared with women who had never used the pill as a contraceptive device, those who did for even short periods of time still had a 15 percent lower chance of suffering from ovarian cancer.

The study found taking the pill had the biggest impact on reducing cancer and was followed by pregnancy and giving birth.

However, health experts from Cancer Research UK have warned this reduced risk of ovarian cancer is equally balanced out by the increased risk of breast cancer women on the pill are subjected to.

To read the latest edition of Healthcare Global, click here

For every 100,000 women who stay on the pill for more than 10 years, there were 15 cases of ovarian cancer and 28 cases in every 100,000 women who used the pill for 12 months or less.

Additionally, women who had experienced a full-term pregnancy were 29 percent less likely to get ovarian cancer than those who had never been pregnant.

Meanwhile, the risk of developing breast cancer stands at 50 extra cases of the disease per 100,000 pill-taking women.

The research is part of the Cancer Research UK funded EPIC project – the European Prospective Investigation of Cancer – which is investigating how lifestyle factors link to cancer.

“Ovarian cancer is difficult to detect and so prevention is key to saving women suffering from this disease,” explained Naomi Allen, an epidemiologist from the charity.

She added: “These results are important because most women don’t know that taking the pill or getting pregnant can help reduce their risk of ovarian cancer later on in life.”

The Director of Health Information at Cancer Research UK, Sara Hiom, said: “These days it is not uncommon for women to have fewer children or none at all.

“Women tend to be unaware that these reproductive factors have a protective effect on their risk of ovarian cancer.

“Treatment for ovarian cancer is better if the disease is caught as early as possible, so all women should be aware of the signs of ovarian cancer like pain in the lower tummy, bloating, increased tummy size, difficulty eating or feeling full,” she said.

The results of the study have been published in the British Journal of Cancer.

Our magazine is now available on the iPad. Click here to download it.

Share

Featured Articles

UPS Healthcare Addressing Connected Logistics Needs

UPS Healthcare is meeting increased need for integrated, globally connected healthcare logistics services in Republic of Ireland, where pharma is booming

HPV Vaccine 'Protects Males from Cancers' - Global Report

As a new report shows the human papillomavirus vaccine can also protect men and boys, we take a look at HPV vaccines, and their impact on world health

Tata Consultancy Report Shows AI in Healthcare on Rise

Tata Consultancy Services AI for Business Global Study shows that three-quarters of healthcare leaders are deploying AI to drive innovation and efficiency

McKinsey: Consumers Demand Data-driven Wellness Products

Medical Devices & Pharma

SpaceX Starlink Launch Boost for Indonesia Healthcare

Technology & AI

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Sustainability